Previous Article | Next Article ![]()
Journal of Virology, August 2008, p. 7725-7728, Vol. 82, No. 15
0022-538X/08/$08.00+0 doi:10.1128/JVI.00237-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

L. B. Thackray,2,
and
I. G. Goodfellow1*
Department of Virology, Faculty of Medicine, Imperial College London, St. Mary's Campus, Norfolk Place, London W2 1PG, United Kingdom,1 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri2
Received 2 February 2008/ Accepted 10 May 2008
Murine norovirus (MNV), a prevalent pathogen of laboratory mice, shares many characteristics with human noroviruses. Previous results indicated that passage of MNV1 in the macrophage cell line RAW 264.7 results in attenuation in STAT1-deficient mice (C. E. Wobus, S. M. Karst, L. B. Thackray, K. O. Chang, S. V. Sosnovtsev, G. Belliot, A. Krug, J. M. Mackenzie, K. Y. Green, and H. W. Virgin, PLoS. Biol. 2:e432, 2004). Sequence analysis revealed two amino acid differences between the virulent and attenuated viruses. Using an infectious cDNA clone of the attenuated virus, we demonstrated that a glutamate-to-lysine substitution at position 296 in the capsid protein (VP1) is sufficient to restore virulence in vivo, identifying, for the first time, a virus-encoded molecular determinant of norovirus virulence.
Published ahead of print on 21 May 2008.
These authors contributed equally to the work.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»